Register
FDA approves first generic drug under new pathway aimed at enhancing market competition for sole source drugs |
Journal Updates
eMediNexus Coverage from: 
FDA approves first generic drug under new pathway aimed at enhancing market competition for sole source drugs
eMediNexus,  09 August 2018
remove_red_eye 604 Views
#Pathology and Lab Medicine #Pharmacist

0 Read Comments                

The U.S. Food and Drug Administration today approved several strengths of potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy (CGT) designation. This new approval pathway was created to expedite the development and review of a generic drug for products that lack competition. Potassium chloride is an oral treatment that is indicated for the treatment and prevention of hypokalemia (low potassium blood levels) in patients who are on diuretics, an

To continue reading this article
Or

Continue reading your article with a Emedinexus account..
Free Membership!